Michael Finney Net Worth

The estimated Net Worth of Michael J. Finney is at least 504 千$ dollars as of 18 June 2021. Michael Finney owns over 21,700 units of Vaxart Inc stock worth over 445,816$ and over the last 7 years he sold VXRT stock worth over 0$. In addition, he makes 58,411$ as Independent Director at Vaxart Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Michael Finney VXRT stock SEC Form 4 insiders trading

Michael has made over 3 trades of the Vaxart Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 21,700 units of VXRT stock worth 14,756$ on 18 June 2021.

The largest trade he's ever made was buying 181,818 units of Vaxart Inc stock on 11 April 2019 worth over 200,000$. On average, Michael trades about 18,956 units every 101 days since 2018. As of 18 June 2021 he still owns at least 474,272 units of Vaxart Inc stock.

You can see the complete history of Michael Finney stock trades at the bottom of the page.

Michael Finney biography

Dr. Michael J. Finney Ph.D. serves as Independent Director of the Company. He has served as a member of our board of directors since February 2018 and previously served as a member of Private Vaxart’s board of directors since 2007. Since October 2004, Dr. Finney has served as the Managing Director of Finney Capital, an investment firm. Since 1986, Dr. Finney has served as a founder, director and/or investor in various life sciences companies. Currently, he sits on six private company boards. From 2009 to 2011, Dr. Finney served as Vaxart’s Chief Executive Officer. Dr. Finney received an A.B. in biochemical sciences from Harvard University and a Ph.D. in biology (genetics) from the Massachusetts Institute of Technology.

What is the salary of Michael Finney?

As the Independent Director of Vaxart Inc, the total compensation of Michael Finney at Vaxart Inc is 58,411$. There are 7 executives at Vaxart Inc getting paid more, with Wouter Latour having the highest compensation of 747,711$.

How old is Michael Finney?

Michael Finney is 61, he's been the Independent Director of Vaxart Inc since 2018. There are 4 older and 8 younger executives at Vaxart Inc. The oldest executive at Vaxart Inc is Anne VanLent, 72, who is the Independent Director.

What's Michael Finney's mailing address?

Michael's mailing address filed with the SEC is C/O VAXART, INC., 170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Vaxart Inc

Over the last 7 years, insiders at Vaxart Inc have traded over 322,706,538$ worth of Vaxart Inc stock and bought 8,979,091 units worth 2,899,807$ . The most active insiders traders include Capital, Llc Armistice Capi...、Steven Lo、Wouter Latour. On average, Vaxart Inc executives and independent directors trade stock every 57 days with the average trade being worth of 1,309,363$. The most recent stock trade was executed by W. Mark Watson on 18 June 2024, trading 20,000 units of VXRT stock currently worth 13,600$.

What does Vaxart Inc do?

since its founding in 2004, vaxart has pursued a vision of advancing vaccines—to make them as tablets rather than injections. the company’s proprietary oral vaccine delivery platform is suitable to deliver any recombinant vaccine, positioning vaxart to introduce oral forms of multiple vaccines in the rapidly growing global vaccines market.

Complete history of Michael Finney stock trades at Vaxart Inc

Vaxart Inc executives and stock owners

Vaxart Inc executives and other stock owners filed with the SEC include:

• Wouter Latour,
  Chairman of the Board
• Cezar Andrei Floroiu M.B.A.,
  CEO, Pres, Principal Financial Officer & Director
• Dr. Sean N. Tucker,
  Sr. VP & Chief Scientific Officer
• Margaret A. Echerd,
  Sr. VP & Principal Accounting Officer
• Sean Tucker,
  Chief Scientific Officer
• Margaret Echerd,
  Principal Accounting Officer, Vice President, Controller
• Anne VanLent,
  Independent Director
• Michael Finney,
  Independent Director
• Robert Yedid,
  Lead Independent Director
• Todd Davis,
  Independent Director
• Karen Wilson,
  Independent Director
• Keith Maher,
  Director
• Steven Boyd,
  Director
• Andrei Floroiu,
  Chief Executive Officer, Principal Financial Officer, Director
• Edward B. Berg,
  Sr. VP & Gen. Counsel
• John M. Harland M.B.A., CPA,
  Consultant
• Dr. James F. Cummings M.D.,
  Chief Medical Officer
• Dr. Rajesh Kapoor Ph.D.,
  Sr. VP of Quality
• Dr. Richard M. Schwartz,
  Sr. VP of Technical Operations
• Brant Biehn,
  Sr. VP of Bus. Operations
• Shaily Jaini Garg,
  Sr. VP of Clinical Devel. & Project Management
• Julie M Cherrington,
  Director
• Edward B Berg,
  SVP, General Counsel
• John M Harland,
  Chief Financial Officer
• Richard J Markham,
  Director
• Geoffrey F Cox,
  Director
• John P Richard,
  Director
• Phillip E Lee,
  Chief Financial Officer
• David E. Wheadon,
  Director
• James F. Cummings,
  Chief Medical Officer
• W. Mark Watson,
  Director
• Elaine J Heron,
  Director
• Steven Lo,
  President, Chief Exec Officer
• Fuad Ahmad,
  Interim CFO